Conditions: Healthy Participants
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 16
Healthy volunteers: yes

Brief summary:
The study involves a single dose of LY2409021 taken by mouth. The purpose of this study is to determine how much LY2409021 enters the bloodstream and how long the body takes to get rid of the drug after the dose. This study will last approximately 28 days, not including screening. Screening can occur within 30 days prior to the start of the study.

Detailed description:

Arms:
arm 1: Single oral dose of 20 milligrams (mg) LY2409021.

Interventions: intervention 1: LY2409021
Intervention descriptions: intervention 1: None

Protocol document: